Lincomycin
Paul A. Pham, Pharm.D., John G. Bartlett, M.D.
INDICATIONS
INDICATIONS
INDICATIONS
FDA
FDA
- Treatment of serious infections caused by susceptible strains of streptococci, pneumococci, and staphylococci in PCN-allergic patients.
- Only IV formulation is available in U.S.
There's more to see -- the rest of this topic is available only to subscribers.
© 2000–2024 Unbound Medicine, Inc. All rights reserved